E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced β-Catenin-Tcf/Lef-Dependent Transcription

REFERENCES

• Altieri, D. C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3:46–54.
   PubMed Web of Science ®Google Scholar
• Bender, F., M. Montoya, V. Monardes, L. Leyton, and A. F. Quest. 2002. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35:151–167.
   PubMed Web of Science ®Google Scholar
• Bender, F. C., M. A. Reymond, C. Bron, and A. F. Quest. 2000. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60:5870–5878.
   PubMed Web of Science ®Google Scholar
• Brembeck, F. H., M. Rosario, and W. Birchmeier. 2006. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16:51–59.
   PubMed Web of Science ®Google Scholar
• Cao, H., W. E. Courchesne, and C. C. Mastick. 2002. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J. Biol. Chem. 277:8771–8774.
   PubMed Web of Science ®Google Scholar
• Cavallaro, U., and G. Christofori. 2004. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4:118–132.
   PubMed Web of Science ®Google Scholar
• Cohen, A. W., R. Hnasko, W. Schubert, and M. P. Lisanti. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84:1341–1379.
   PubMed Web of Science ®Google Scholar
• Costes, S. V., D. Daelemans, E. H. Cho, Z. Dobbin, G. Pavlakis, and S. Lockett. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86:3993–4003.
   PubMed Web of Science ®Google Scholar
• Dajani, R., E. Fraser, S. M. Roe, M. Yeo, V. M. Good, V. Thompson, T. C. Dale, and L. H. Pearl. 2003. Structural basis for recruitment of glycogen synthase kinase 3β to the axin-APC scaffold complex. EMBO J. 22:494–501.
   PubMed Web of Science ®Google Scholar
• Dohi, T., K. Okada, F. Xia, C. E. Wilford, T. Samuel, K. Welsh, H. Marusawa, H. Zou, R. Armstrong, S. Matsuzawa, G. S. Salvesen, J. C. Reed, and D. C. Altieri. 2004. An IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 279:34087–34090.
   PubMed Web of Science ®Google Scholar
• Felley-Bosco, E., F. Bender, and A. F. Quest. 2002. Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells. Biol. Res. 35:169–176.
   PubMedGoogle Scholar
• Felley-Bosco, E., F. C. Bender, F. Courjault-Gautier, C. Bron, and A. F. Quest. 2000. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 97:14334–14339.
   PubMed Web of Science ®Google Scholar
• Fiucci, G., D. Ravid, R. Reich, and M. Liscovitch. 2002. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21:2365–2375.
   PubMed Web of Science ®Google Scholar
• Galbiati, F., D. Volonte, A. M. Brown, D. E. Weinstein, A. Ben-Ze'ev, R. G. Pestell, and M. P. Lisanti. 2000. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J. Biol. Chem. 275:23368–23377.
   PubMed Web of Science ®Google Scholar
• Galbiati, F., D. Volonte, J. Liu, F. Capozza, P. G. Frank, L. Zhu, R. G. Pestell, and M. P. Lisanti. 2001. Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol. Biol. Cell 12:2229–2244.
   PubMed Web of Science ®Google Scholar
• Gao, Y., and H. Y. Wang. 2006. Casein kinase 2 is activated and essential for wnt/beta-catenin signaling. J. Biol. Chem. 281:18394–18400.
   PubMedGoogle Scholar
• Gottardi, C. J., and B. M. Gumbiner. 2004. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J. Cell Biol. 167:339–349.
   PubMed Web of Science ®Google Scholar
• Gottardi, C. J., E. Wong, and B. M. Gumbiner. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153:1049–1060.
   PubMed Web of Science ®Google Scholar
• Harris, T. J., and M. Peifer. 2005. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol. 15:234–237.
   PubMed Web of Science ®Google Scholar
• Hetz, C. A., M. Hunn, P. Rojas, V. Torres, L. Leyton, and A. F. Quest. 2002. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. J. Cell Sci. 115:4671–4683.
   PubMed Web of Science ®Google Scholar
• Ho, C. C., P. H. Huang, H. Y. Huang, Y. H. Chen, P. C. Yang, and S. M. Hsu. 2002. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol. 161:1647–1656.
   PubMed Web of Science ®Google Scholar
• Hulit, J., T. Bash, M. Fu, F. Galbiati, C. Albanese, D. R. Sage, A. Schlegel, J. Zhurinsky, M. Shtutman, A. Ben-Ze'ev, M. P. Lisanti, and R. G. Pestell. 2000. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:21203–21209.
   PubMed Web of Science ®Google Scholar
• Iurlaro, M., F. Demontis, M. Corada, L. Zanetta, C. Drake, M. Gariboldi, S. Peiro, A. Cano, P. Navarro, A. Cattelino, S. Tognin, P. C. Marchisio, and E. Dejana. 2004. VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Am. J. Pathol. 165:181–189.
   PubMedGoogle Scholar
• Kim, P. J., J. Plescia, H. Clevers, E. R. Fearon, and D. C. Altieri. 2003. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362:205–209.
   PubMed Web of Science ®Google Scholar
• Kimelman, D., and W. Xu. 2006. β-Catenin destruction complex: insights and questions from a structural perspective. Oncogene 25:7482–7491.
   PubMed Web of Science ®Google Scholar
• Korabiowska, M., T. Schlott, N. Siems, A. Muller, C. Cordon-Cardo, G. Fischer, and U. Brinck. 2004. Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours. Mod. Pathol. 17:1539–1544.
   PubMedGoogle Scholar
• Lavie, Y., G. Fiucci, and M. Liscovitch. 1998. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273:32380–32383.
   PubMed Web of Science ®Google Scholar
• Lavie, Y., and M. Liscovitch. 2000. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconj. J. 17:253–259.
   PubMed Web of Science ®Google Scholar
• Lee, S. W., C. L. Reimer, P. Oh, D. B. Campbell, and J. E. Schnitzer. 1998. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391–1397.
   PubMed Web of Science ®Google Scholar
• Li, F., G. Ambrosini, E. Y. Chu, J. Plescia, S. Tognin, P. C. Marchisio, and D. C. Altieri. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584.
   PubMed Web of Science ®Google Scholar
• Li, J., G. S. Hassan, T. M. Williams, C. Minetti, R. G. Pestell, H. B. Tanowitz, P. G. Frank, F. Sotgia, and M. P. Lisanti. 2005. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle 4:1817–1825.
   PubMed Web of Science ®Google Scholar
• Li, L., G. Yang, S. Ebara, T. Satoh, Y. Nasu, T. L. Timme, C. Ren, J. Wang, S. A. Tahir, and T. C. Thompson. 2001. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 61:4386–4392.
   PubMed Web of Science ®Google Scholar
• Lilien, J., and J. Balsamo. 2005. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 17:459–465.
   PubMed Web of Science ®Google Scholar
• Liu, C., Y. Li, M. Semenov, C. Han, G. H. Baeg, Y. Tan, Z. Zhang, X. Lin, and X. He. 2002. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837–847.
   PubMed Web of Science ®Google Scholar
• Liu, J., P. Lee, F. Galbiati, R. N. Kitsis, and M. P. Lisanti. 2001. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol. 280:C823–C835.
   PubMedGoogle Scholar
• Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408.
   PubMed Web of Science ®Google Scholar
• Logan, C. Y., and R. Nusse. 2004. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781–810.
   PubMed Web of Science ®Google Scholar
• Lu, Z., S. Ghosh, Z. Wang, and T. Hunter. 2003. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4:499–515.
   PubMed Web of Science ®Google Scholar
• Lu, Z., and T. Hunter. 2004. Wnt-Independent beta-catenin transactivation in tumor development. Cell Cycle 3:571–573.
   PubMedGoogle Scholar
• Mehlen, P., and A. Puisieux. 2006. Metastasis: a question of life or death. Nat. Rev. Cancer 6:449–458.
   PubMed Web of Science ®Google Scholar
• Miotti, S., A. Tomassetti, I. Facetti, E. Sanna, V. Berno, and S. Canevari. 2005. Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases. Am. J. Pathol. 167:1411–1427.
   PubMedGoogle Scholar
• Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J. Biol. Chem. 273:5419–5422.
   PubMed Web of Science ®Google Scholar
• Potter, E., C. Bergwitz, and G. Brabant. 1999. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr. Rev. 20:207–239.
   PubMed Web of Science ®Google Scholar
• Qi, J., J. Wang, O. Romanyuk, and C. H. Siu. 2006. Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. Mol. Biol. Cell 17:1261–1272.
   PubMed Web of Science ®Google Scholar
• Quest, A. F., L. Leyton, and M. Parraga. 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol. 82:129–144.
   PubMed Web of Science ®Google Scholar
• Racine, C., M. Belanger, H. Hirabayashi, M. Boucher, J. Chakir, and J. Couet. 1999. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 255:580–586.
   PubMed Web of Science ®Google Scholar
• Razani, B., S. E. Woodman, and M. P. Lisanti. 2002. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54:431–467.
   PubMed Web of Science ®Google Scholar
• Reifenberger, J., C. B. Knobbe, M. Wolter, B. Blaschke, K. W. Schulte, T. Pietsch, T. Ruzicka, and G. Reifenberger. 2002. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int. J. Cancer 100:549–556.
   PubMed Web of Science ®Google Scholar
• Shin, S., B. J. Sung, Y. S. Cho, H. J. Kim, N. C. Ha, J. I. Hwang, C. W. Chung, Y. K. Jung, and B. H. Oh. 2001. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117–1123.
   PubMed Web of Science ®Google Scholar
• Song, Z., X. Yao, and M. Wu. 2003. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis. J. Biol. Chem. 278:23130–23140.
   PubMed Web of Science ®Google Scholar
• Sotgia, F., T. M. Williams, A. W. Cohen, C. Minetti, R. G. Pestell, and M. P. Lisanti. 2005. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle 4:1808–1816.
   PubMed Web of Science ®Google Scholar
• Sotgia, F., T. M. Williams, W. Schubert, F. Medina, C. Minetti, R. G. Pestell, and M. P. Lisanti. 2006. Caveolin-1 deficiency (−/−) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am. J. Pathol. 168:292–309.
   PubMedGoogle Scholar
• Tahir, S. A., G. Yang, S. Ebara, T. L. Timme, T. Satoh, L. Li, A. Goltsov, M. Ittmann, J. D. Morrisett, and T. C. Thompson. 2001. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61:3882–3885.
   PubMed Web of Science ®Google Scholar
• Tamm, I., Y. Wang, E. Sausville, D. A. Scudiero, N. Vigna, T. Oltersdorf, and J. C. Reed. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
   PubMed Web of Science ®Google Scholar
• Tapia, J. C., V. A. Torres, D. A. Rodriguez, L. Leyton, and A. F. Quest. 2006. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc. Natl. Acad. Sci. USA 103:15079–15084.
   PubMed Web of Science ®Google Scholar
• Torres, V. A., J. C. Tapia, D. A. Rodriguez, M. Parraga, P. Lisboa, M. Montoya, L. Leyton, and A. F. Quest. 2006. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J. Cell Sci. 119:1812–1823.
   PubMed Web of Science ®Google Scholar
• van de Wetering, M., R. Cavallo, D. Dooijes, M. van Beest, J. van Es, J. Loureiro, A. Ypma, D. Hursh, T. Jones, A. Bejsovec, M. Peifer, M. Mortin, and H. Clevers. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789–799.
   PubMed Web of Science ®Google Scholar
• Wheelock, M. J., and K. R. Johnson. 2003. Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 19:207–235.
   PubMed Web of Science ®Google Scholar
• Wiechen, K., L. Diatchenko, A. Agoulnik, K. M. Scharff, H. Schober, K. Arlt, B. Zhumabayeva, P. D. Siebert, M. Dietel, R. Schafer, and C. Sers. 2001. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:1635–1643.
   PubMedGoogle Scholar
• Wiechen, K., C. Sers, A. Agoulnik, K. Arlt, M. Dietel, P. M. Schlag, and U. Schneider. 2001. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158:833–839.
   PubMed Web of Science ®Google Scholar
• Wong, N. A., and M. Pignatelli. 2002. Beta-catenin—a linchpin in colorectal carcinogenesis? Am. J. Pathol. 160:389–401.
   PubMed Web of Science ®Google Scholar
• Worm, J., C. Christensen, K. Gronbaek, E. Tulchinsky, and P. Guldberg. 2004. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23:5215–5226.
   PubMedGoogle Scholar
• Yang, G., L. D. Truong, T. L. Timme, C. Ren, T. M. Wheeler, S. H. Park, Y. Nasu, C. H. Bangma, M. W. Kattan, P. T. Scardino, and T. C. Thompson. 1998. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4:1873–1880.
   PubMed Web of Science ®Google Scholar
• Yang, G., L. D. Truong, T. M. Wheeler, and T. C. Thompson. 1999. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 59:5719–5723.
   PubMed Web of Science ®Google Scholar
• Zhang, T., T. Otevrel, Z. Gao, S. M. Ehrlich, J. Z. Fields, and B. M. Boman. 2001. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61:8664–8667.
   PubMed Web of Science ®Google Scholar
• Zhang, W., B. Razani, Y. Altschuler, B. Bouzahzah, K. E. Mostov, R. G. Pestell, and M. P. Lisanti. 2000. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275:20717–20725.
   PubMed Web of Science ®Google Scholar